How long after taking Mounjaro does it start working?

The first two weeks: your body adjusting, not failing

The decision most people wrestle with after the first injection is this: is it working, or is nothing happening? The answer, almost always, is that something is happening, just not visibly yet.

Tirzepatide activates both GIP and GLP-1 receptors involved in appetite regulation and gastric emptying. That dual action begins as the medicine is absorbed, typically peaking around 24–72 hours after injection. But the 2.5mg starting dose is a tolerability dose. Its job is to settle your system, not to drive weight loss, so if appetite feels broadly unchanged in week one, that is entirely expected.

What you may notice instead: mild nausea, a slight sense of fullness earlier in meals, or a quieter interest in food by mid-week two. These are signs the medicine is doing exactly what it should. The NHS patient information on tirzepatide describes these early gastrointestinal effects as common and usually settling within days to a couple of weeks. Try not to judge the medicine's effectiveness against this first fortnight; it is genuinely the on-boarding phase.

One practical note: plan your injection day so it doesn't coincide with anything demanding. Many people find the 48 hours after their first or second dose involves some fatigue or nausea, not dangerous, but worth accounting for. If you are unsure what to expect in those opening days, our guide on how long it takes for Mounjaro to start working walks through the typical timeline in detail.

Weeks four to twelve: when appetite shifts and the scales catch up

This is the window where most people say things feel different. After the prescriber reviews your progress and moves you up the dose ladder, appetite suppression becomes more consistent. Meals that once felt modest now feel sufficient. Snacking drops off without effort. Some people describe it as the mental noise around food becoming quieter.

Weight changes at this stage vary considerably by individual. Some people lose several kilograms in the first eight weeks; others see the scales move more slowly while their eating patterns shift underneath. Both are normal. The SURMOUNT-1 trial, published in the New England Journal of Medicine, followed thousands of adults over 72 weeks, the largest weight losses accumulated steadily across that whole period, not in a dramatic early surge.

If you are transferring from another treatment or comparing your progress to someone else's, pace is genuinely hard to predict. Metabolic rate, starting weight, activity level and how the dose titration goes all play a role. The more useful question to ask yourself is: are my eating habits changing? That shift usually precedes the weight change by several weeks. It can also help to understand how long after taking Mounjaro the effects begin to show, since the gap between dose and noticeable change is often longer than people expect.

For a broader sense of how results accumulate across the full trial programme, the SURMOUNT-1 results page breaks the evidence down in detail.

Beyond three months: the longer arc of treatment

By the time you reach a maintenance dose (whether 10mg, 12.5mg or 15mg) the question shifts from "has it started working" to "is it working well enough to continue." NICE's appraisal of tirzepatide (TA1026) sets a clear benchmark: if weight loss is below 5% after six months at the highest tolerated dose, continuing treatment should be reviewed with your prescriber.

For the majority of people in clinical trials, weight loss continued to accumulate well past the three-month mark. The plateau, if it comes, tends to appear later, often after 12 months or more. That means patience in the early months is clinically justified, not just optimistic. Our page on how fast Mounjaro starts working covers why the early phase looks different from the months that follow.

It is also worth knowing that tirzepatide is a Black Triangle medicine, meaning the MHRA collects additional safety data as its use widens. Your prescriber reviews your progress before every repeat order, at nume, no repeat is dispensed without a clinical re-check. That ongoing oversight is part of how treatment stays safe and appropriately adjusted over time.

If you have questions about how Mounjaro works, the Mounjaro treatment page covers mechanism, eligibility and what the consultation involves. For anything about cost, the Mounjaro price comparison page sets out what private treatment typically includes across providers. And for a broader look at weight-loss treatment options, the weight-loss overview is a useful starting point.

When to get medical help

Most early side effects (nausea, loose stools, low appetite, mild fatigue) are expected and settle with time. But some symptoms need prompt attention. Severe or persistent stomach pain that radiates to your back, particularly alongside vomiting, should be assessed urgently; the MHRA's Drug Safety Update highlights acute pancreatitis as an infrequent but serious known risk with GLP-1 medicines. Gallbladder symptoms, signs of significant dehydration, or any allergic reaction also warrant same-day contact with a healthcare professional.

You can report any suspected side effects directly to the MHRA at yellowcard.mhra.gov.uk. At nume, our prescribers are reachable seven days a week if something concerns you mid-treatment.

If you'd like a clinical assessment of whether Mounjaro is right for you, speak to our prescribers, the consultation is free, and reviewed the same day.